Ngowngarmratana S, Sunthornthepvarakul T, Kanchanawat S
Department of Medicine, Rajvithi Hospital, Bangkok, Thailand.
J Med Assoc Thai. 1997 Nov;80(11):693-9.
Sixty-seven patients with molar pregnancy were studied on admission to Rajvithi Hospital from 1992 to 1996. Thyroid function tests and serum hCG concentrations were measured. On the basis of thyroid function test results, the patients could be subdivided into three groups; Group I (hyperthyroid), Group II (subclinical hyperthyroid) and Group III (nontoxic). We found significant correlation between hCG and T4, T3 and FT4I levels (rho = 0.559, p < 0.001 n = 35; rho = 0.629, p < 0.001 n = 35; and rho = 0.465, p = 0.010 n = 30 respectively). These findings support that a variant hCG is responsible for hyperthyroidism observed in patients with molar pregnancy.
1992年至1996年期间,对67例葡萄胎患者入院时进行了研究。检测了甲状腺功能试验和血清hCG浓度。根据甲状腺功能试验结果,患者可分为三组:第一组(甲状腺功能亢进)、第二组(亚临床甲状腺功能亢进)和第三组(无毒性)。我们发现hCG与T4、T3和FT4I水平之间存在显著相关性(rho分别为0.559,p<0.001,n=35;rho为0.629,p<0.001,n=35;rho为0.465,p=0.010,n=30)。这些发现支持一种变异的hCG是葡萄胎患者中观察到的甲状腺功能亢进的原因。